SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr David Summers who wrote (1064)6/2/1998 5:38:00 PM
From: Jeffrey L. Henken  Read Replies (1) of 2887
 
American BioMed's Chief Clinical Advisor is Dr Samuel S Ahn:

SAMUEL S. AHN, M.D., F.A.C.S. -- Dr. Ahn has served as Chief Clinical
Advisor to the Company since January 1996. Dr. Ahn is Associate Clinical Professor of Surgery at the University of California at Los Angeles. He serves on the editorial board of the Journal of Vascular Surgery, and is a reviewer or guest reviewer for Surgery, Arteriosclerosis, Thrombosis and Vascular Biology, Journal of Endovascular Surgery, Annals of Vascular Surgery, Vascular Surgery, and others. He is author or co-author of over 70 peer review articles, a visiting professor at University of Louisville; Yonsei University, Seoul, Korea; University of Ulm, Ulm, Germany; Ultrech Hospital, Ultrech, Netherlands; Ochsner Clinic and others. He holds membership in the American Medical Association, Association for Academic Surgery, American College of Surgeons (Fellow), Western Vascular Society, Los Angeles Surgical Society, etc.

Pretty impressive CV!



I'll be calling Dr Ahn tonight.



GO ABMI

Regards, Jeff
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext